Relay Therapeutics Relay Therapeutics (NASDAQ: RLAY) Announces Acquisition of ZebiAI Relay Therapeutics, Inc. (NASDAQ: RLAY) disclosed Friday that it has acquired ZebiAI. Both the firms will join hands to speed up the use of ML across the Dynamo platform.
Financial Perhaps Relay Therapeutics, Inc. (RLAY) Has Found Some Support In The Market Place Relay Therapeutics, Inc. (RLAY) has seen some recent volatility in the market and its stock closed trading at $36.94 yesterday. Traders are starting to take notice of RLAY as the stock traded as high as $37.91 and as low as $36.01